Novel Use Of Combination Therapeutic Plasma Exchange And Rituximab In The Treatment Of Nivolumab-Induced Bullous Pemphigoid

INTERNATIONAL JOURNAL OF DERMATOLOGY(2018)

引用 28|浏览18
暂无评分
摘要
International Journal of DermatologyVolume 57, Issue 11 p. 1372-1374 Case Report Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid Alyson V. Ridpath DO, Alyson V. Ridpath DO Dermatology, Ohio Health, Athens, Ohio, USASearch for more papers by this authorPolina V. Rzepka MD, Polina V. Rzepka MD Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this authorSabrina M. Shearer MD, Corresponding Author Sabrina M. Shearer MD sabrina.smith@osumc.edu Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA Correspondence Sabrina M. Shearer, md 540 Officenter Pl, Suite 240 Gahanna, OH 43230 USA E-mail: sabrina.smith@osumc.eduSearch for more papers by this authorScott R. Scrape MD, Scott R. Scrape MD Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this authorThomas E. Olencki DO, Thomas E. Olencki DO Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this authorBenjamin H. Kaffenberger MD, Benjamin H. Kaffenberger MD Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this author Alyson V. Ridpath DO, Alyson V. Ridpath DO Dermatology, Ohio Health, Athens, Ohio, USASearch for more papers by this authorPolina V. Rzepka MD, Polina V. Rzepka MD Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this authorSabrina M. Shearer MD, Corresponding Author Sabrina M. Shearer MD sabrina.smith@osumc.edu Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA Correspondence Sabrina M. Shearer, md 540 Officenter Pl, Suite 240 Gahanna, OH 43230 USA E-mail: sabrina.smith@osumc.eduSearch for more papers by this authorScott R. Scrape MD, Scott R. Scrape MD Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this authorThomas E. Olencki DO, Thomas E. Olencki DO Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this authorBenjamin H. Kaffenberger MD, Benjamin H. Kaffenberger MD Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASearch for more papers by this author First published: 06 April 2018 https://doi.org/10.1111/ijd.13970Citations: 20 Conflicts of interest: The authors have the following conflicts of interest to disclose: Drs. Ridpath, Rzepka, Shearer and Scrape have no conflicts of interest. Dr. Olencki has received funding from Bristol-Myers Squibb, Prometheus, Regeneron and Tracon for clinical research at the Wexner Medical Center at The Ohio State University. None of this funding was directly connected to this report. Dr. Kaffenberger has received funding from Biogene, Celgene, Eli Lilly Company, and XBiotech for clinical research at the Wexner Medical Center at The Ohio State University. None of this funding was directly connected to this report. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume57, Issue11November 2018Pages 1372-1374 RelatedInformation
更多
查看译文
关键词
therapeutic plasma exchange,rituximab,nivolumab-induced
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要